Lung cancer and life expectancy
Once cancer enters the lymph nodes and bloodstream, it can spread anywhere in the body. The outlook is better when treatment begins before cancer spreads outside the lungs.
Other factors include
age, overall health, and how well you respond to treatment. Because early
symptoms can be easily overlooked, lung cancer is usually diagnosed in later
stages.
Survival rates and other
statistics provide a broad picture of what to expect. There are significant
individual differences, though. Your doctor is in the best position to discuss
your outlook.
Current survival
statistics don’t tell the whole story. In recent years, new treatments have
been approved for stage 4 non-small cell lung cancer (NSCLC). Some people are
surviving much longer than previously seen with traditional treatments.
The following are the
estimated five-year survival rates for NSCLC by SEER stage:
- Localized:
60 percent
- Regional:
33 percent
- Distant: 6
percent
- All SEER
stages: 23 percent
Small-cell lung cancer
(SCLC) is very aggressive. For limited stage SCLC, the five-year survival rate
is 14 percent Trusted Source. Median survival is 16 to 24 months. Median
survival for extensive stage SCLC is six to 12 months.
Long-term disease-free
survival is rare. Without treatment, median survival from diagnosis of SCLC is
only two to four months.
The relative five-year
survival rate for mesothelioma, a type of cancer caused by asbestos exposure,
is 5 to 10 percent.
Comments
Post a Comment